Furthermore, recent studies have demonstrated that IL-33 played a critical role in obesity-associated inflammation, atherosclerosis, and metabolic abnormalities through promoting the production of T helper type 2 (Th2) cytokines and polarizing macrophages towards a protective alternatively activated phenotype. This evidence concerns the gene IL33 and atherosclerosis.